Skip to content
Other Eye Conditions

Eye Dock (Comprehensive Eye Examination and Eye Dock)

1. What is Eye Dock (Ophthalmology Checkup)?

Section titled “1. What is Eye Dock (Ophthalmology Checkup)?”

Eye Dock (ophthalmology checkup) is a comprehensive eye examination program for asymptomatic healthy individuals, paid out-of-pocket, aimed at early detection and prevention of eye diseases. It is positioned as an ophthalmology-specific version of a general health checkup and differs from regular insurance-covered medical care.

Insurance-covered ophthalmology visits assume the presence of some symptoms or disease. In contrast, Eye Dock aims to comprehensively evaluate the eye condition from a stage with no subjective symptoms and detect diseases in the asymptomatic phase.

The main screening target diseases are as follows:

  • Glaucoma: By the time visual field defects are noticed, approximately 40% of retinal ganglion cells (cells responsible for vision) have been lost2)
  • Age-related macular degeneration (AMD): Early detection is important because it takes several to over ten years from precursor lesions (drusen) to progression8)
  • Diabetic retinopathy: Even in the asymptomatic stage, regular examinations can suppress progression3)
  • Cataracts: Clouding of the lens can be detected before it is perceived as decreased visual acuity
  • Retinal detachment and macular hole: The risk of developing these conditions is particularly high in people with high myopia4)

Data on the prevalence of eye diseases support the need for eye health checkups.

The prevalence of glaucoma is about 5% in people aged 40 and older (Tajimi Study, 2004)1). Approximately 90% of these cases are undiagnosed and have not received medical attention, indicating that the majority of affected individuals have not been examined1). The prevalence of age-related macular degeneration was reported in the Hisayama Study (9-year follow-up) with a cumulative incidence of exudative AMD of 1.6%8). These data highlight the need for regular eye examinations.

In the early stages of glaucoma, there is almost no awareness of visual field defects. In many cases, symptoms are only noticed when damage to the optic nerve progresses and affects central vision. By the time visual field loss is perceived, a considerable loss of retinal ganglion cells has already occurred, making regular checkups virtually the only means of early detection2).

Q What is the difference between an eye health checkup and a regular eye clinic visit?
A

An eye health checkup is a comprehensive, self-funded eye examination program targeting healthy individuals without symptoms, aimed at detecting glaucoma, age-related macular degeneration, diabetic retinopathy, and other conditions at an asymptomatic stage. In contrast, a regular eye clinic visit under insurance is conducted based on eye symptoms (such as blurred vision, redness, pain) or existing eye diseases. The key difference is that an eye health checkup combines multiple tests such as visual acuity, intraocular pressure, fundus examination, OCT, and visual field testing for a comprehensive evaluation.

Section titled “2. Target Population and Recommended Timing”

The target population for eye health checkups is broad. Regular checkups are especially recommended for those who meet the following conditions:

Target groupRecommended frequency
General adults aged 40 and overOnce a year
Individuals at risk for glaucoma (myopia, family history)Once a year or more
Patients with diabetesOnce a year or more (fundus examination)
Individuals with high myopiaOnce a year or more
Q At what age should one start having an eye exam (I-dock)?
A

Generally, age 40 is considered the standard. The Glaucoma Practice Guidelines (5th edition)2) recommend regular fundus and intraocular pressure examinations for individuals aged 40 and over. However, if you have high myopia (-6D or more) or a family history of glaucoma or age-related macular degeneration, it is advisable to consider regular examinations before age 40. If diagnosed with diabetes, regardless of age, a fundus examination should be performed immediately after diagnosis3).

Clinical photograph of an ophthalmic examination using a slit lamp microscope. A thin slit of light is directed onto the eye and observed through the microscope.
Clinical photograph of an ophthalmic examination using a slit lamp microscope. A thin slit of light is directed onto the eye and observed through the microscope.
OKJaguar. Slit lamp eye examination. Wikimedia Commons. 2019. License: CC BY-SA 4.0. https://commons.wikimedia.org/wiki/File:Slit_lamp_eye_examination.jpg
Clinical photograph of a slit lamp examination, where a thin slit beam of light is directed onto the patient’s eye while observing the anterior segment, lens, and vitreous body with a biomicroscope. This corresponds to the slit lamp examination discussed in the section “3. Details of Examination.”

Eye examinations are divided into “basic examinations” and “extended examinations.” Although the combination varies by facility, the following items are generally included.

Examination ItemDescription / Evaluation TargetCategory
Visual Acuity Test (Uncorrected / Corrected)Best corrected visual acuity, evaluation of refractive errorBasic
Intraocular Pressure MeasurementMeasured with non-contact or Goldmann applanation tonometerBasic
Slit Lamp ExaminationEvaluation of anterior segment (cornea, conjunctiva) and lensBasic
Dilated fundus examinationDirect observation of optic disc, macula, and peripheral retinaBasic
Fundus photographyDocumentation of retina and optic disc; wide-angle imaging for peripheral evaluation6)Enhanced
OCT examinationCross-sectional imaging of macula and optic disc; RNFL thickness measurement5)Enhanced
Visual field testHumphrey static perimetry is standard2)Enhanced
Corneal thickness measurementNecessary for intraocular pressure correction and glaucoma risk assessment2)Enhanced
Corneal curvature radius measurementCorneal shape and myopia assessmentExpanded
Color vision testScreening for congenital color vision deficiency and acquired color vision disordersExpanded
Contrast sensitivity testAssessment of visual quality decline due to cataracts and neurological diseasesExpanded
AI fundus screeningAutomated diagnosis using deep learning 7)Expanded (some facilities)

OCT (Optical Coherence Tomography) is a non-invasive test that uses light interference to produce cross-sectional images of the retina and optic nerve 5). It can quantitatively assess the layered structure of the macula and the thickness of the retinal nerve fiber layer (RNFL) with a resolution of 10 μm or less. It is particularly useful for early diagnosis of glaucoma and detection of precursor lesions of age-related macular degeneration.

Humphrey static perimetry is a standard visual field test that uses a computer to quantify light sensitivity at various points in the visual field 2). It is the most reliable method for diagnosing and monitoring glaucoma progression, and it forms the core of the expanded tests at iDoc.

Wide-field fundus photography can record the peripheral retina in a single shot, unlike conventional fundus cameras 6). It is excellent for detecting peripheral retinal lesions such as retinal tears and lattice degeneration, and is particularly useful for examining high myopes.

AI fundus screening is a system that uses deep learning algorithms to automatically detect diabetic retinopathy, glaucoma, AMD, etc. from fundus images 7). High sensitivity and specificity have been reported in multi-ethnic cohort validations, and its practical use as a screening tool in areas lacking ophthalmologists is advancing 7).

4. Interpretation of test results and next steps

Section titled “4. Interpretation of test results and next steps”

If an abnormality is detected in the eye check, the patient will transition to detailed examination and treatment within the framework of insurance-covered medical care. The main flow for each disease is shown below.

DiseaseFindings in eye checkNext steps
Suspected glaucomaOptic disc cupping enlargement, RNFL thinning, high intraocular pressureDetailed visual field test (Humphrey), corneal thickness measurement, start eye drops if necessary 2)
Suspected age-related macular degenerationDrusen, pigment abnormalities, exudative findingsDetailed OCT analysis, fluorescein fundus angiography (FAG/ICGA) 8)
Suspected diabetic retinopathyMicroaneurysms, dot hemorrhages, hard exudatesDetailed dilated fundus examination, FAG if necessary 3)
CataractNuclear sclerosis, cortical opacity, posterior subcapsular opacityAssess degree of visual impairment and impact on daily life to determine surgical indication
Retinal tear, lattice degenerationPeripheral retinal degeneration and tearFollow-up with laser photocoagulation4)

Meaningful visit even if results are “within normal range”

Section titled “Meaningful visit even if results are “within normal range””

Even if no abnormalities are found, an eye exam is meaningful because the current condition of the eyes is recorded. Recording baseline values of the optic disc and retina allows comparison and tracking of future changes. Especially for glaucoma, which is evaluated by comprehensive changes in intraocular pressure, optic nerve, and visual field, multiple records improve diagnostic accuracy2).

Q What happens if an abnormality is found during an eye exam?
A

Eye exams are only screenings; diagnosis and treatment are performed under health insurance. If an abnormality is noted, you will undergo a detailed examination under health insurance at the facility where the eye exam was performed or at a specialized facility. If glaucoma is suspected, detailed visual field testing and detailed OCT analysis will be added; if age-related macular degeneration is suspected, fluorescein angiography will be added. Once the disease is confirmed by detailed examination, standard treatment for that disease will be initiated. Early detection and intervention can help preserve visual function.

Eye exams are self-pay and not covered by health insurance. Costs vary depending on the facility and tests, but generally range from 5,000 to 30,000 yen.

  • Basic course (visual acuity, intraocular pressure, slit lamp, fundus): approximately 5,000–10,000 yen
  • Extended course (above + OCT, visual field, fundus photography): approximately 15,000–25,000 yen
  • Full course (including all advanced tests): approximately 25,000–50,000 yen

The cost varies because the types of examination equipment (e.g., OCT generation, presence of wide-field fundus camera) and the number of test items differ by facility.

Facilities where you can receive the examination

Section titled “Facilities where you can receive the examination”
  • Eye checkup programs at university hospitals and general hospitals
  • Comprehensive examination courses at ophthalmology clinics
  • Optional eye examinations at health checkup centers and comprehensive medical checkups (Ningen Dock)
  • May also be offered as an optional test in corporate health checkups or life insurance examinations

The increasing prevalence of visual impairment imposes a substantial economic burden on healthcare. In the United States, the annual economic loss due to major visual impairment in adults is estimated to exceed $35 billion 9). Regular eye checkups (I-Dock) for early detection and treatment are cost-effective, as they can prevent expensive treatments and productivity loss caused by visual impairment.

Q How much does an eye checkup (I-Dock) cost?
A

The cost varies by facility and examination content, but generally ranges from 5,000 to 30,000 yen. Courses range from basic four-item tests (visual acuity, intraocular pressure, slit-lamp examination, and dilated fundus examination) to full courses including OCT, visual field testing, and wide-field fundus photography. All are self-pay services and not covered by health insurance. However, if an abnormality is detected, subsequent detailed examinations and treatments can be covered by insurance.

6. Background and significance of screening

Section titled “6. Background and significance of screening”

The major eye diseases detected by I-Dock share a common feature: the disease progresses before symptoms appear. The scientific basis for screening is summarized below.

Glaucoma: A progressive disease with a long asymptomatic period

Section titled “Glaucoma: A progressive disease with a long asymptomatic period”

In glaucoma, approximately 40% of retinal ganglion cells are lost by the time visual field defects become noticeable 2). According to the Tajimi Study, the prevalence of glaucoma in people aged 40 and older is about 5%, but approximately 90% of those are undiagnosed and have not visited a doctor 1). Moreover, many cases of glaucoma in Japanese people have intraocular pressure within the statistically normal range (normal-tension glaucoma), so a high proportion are missed by intraocular pressure measurement alone 1). Early detection using a combination of OCT and visual field testing is the only effective strategy 2).

Section titled “Age-Related Macular Degeneration: Progression from Drusen Takes Years”

Age-related macular degeneration progresses from early lesions (drusen and pigment epithelial abnormalities) to exudative or atrophic forms over a period of several years to more than a decade 8). The Hisayama Study reported a cumulative incidence of exudative AMD of 1.6% over 9 years of follow-up, and the number of affected individuals is expected to increase with aging 8). If precursor lesions (drusen, retinal pigment epithelial abnormalities) can be detected by OCT and fundus photography at an early stage, early intervention with anti-VEGF therapy becomes possible.

Diabetic Retinopathy: Regular Examinations Linked to Blood Glucose Control

Section titled “Diabetic Retinopathy: Regular Examinations Linked to Blood Glucose Control”

Diabetic retinopathy is one of the three major complications of diabetes, and its progression can be suppressed by a combination of regular fundus examinations and blood glucose control 3). Detection at an asymptomatic early stage (simple diabetic retinopathy) has the greatest impact on treatment efficacy. It is recommended that patients with diabetes undergo a fundus examination immediately after diagnosis and continue to have fundus examinations at least once a year thereafter 3).

High myopia (pathological myopia with excessive elongation of the axial length) increases the risk of various complications such as glaucoma, macular degeneration, cataracts, and retinal detachment 4). Macular lesions associated with pathological myopia follow a unique progression pattern (diffuse atrophy → patchy atrophy → macular neovascularization, etc.), and regular monitoring with OCT is useful for evaluating progression 4).

Importance of Early Detection as Shown by Epidemiological Data

Section titled “Importance of Early Detection as Shown by Epidemiological Data”
DiseasePrevalence/IncidenceSource
Glaucoma (age 40 and over)Approximately 5% (of which about 90% undiagnosed)Tajimi Study 1)
Age-Related Macular Degeneration (exudative type)9-year cumulative incidence 1.6%Hisayama Study 8)
Diabetic retinopathy (diabetes patients)Approximately 40-50% develop within 10 years after diagnosisNational statistics 3)
Cataract (age 70 and older)Prevalence approximately 70-80%National statistics

These data support the importance of continuing regular eye screening from the asymptomatic stage, rather than waiting for specific symptoms to appear. Vision is a function directly linked to daily life, work, and quality of life (QOL), and preserving visual function through early detection greatly contributes to patients’ long-term quality of life 9).

Practical Application of AI Fundus Screening

Section titled “Practical Application of AI Fundus Screening”

Automated fundus diagnosis using deep learning is rapidly moving toward practical application. In a multi-ethnic cohort study by Ting et al. (2017), a deep learning system was shown to accurately detect diabetic retinopathy, suspected glaucoma, and AMD automatically 7). Research is also progressing on simple fundus photography systems combined with smartphone cameras, which are expected to serve as screening tools in areas with limited access to ophthalmologists 7).

Remote fundus image reading using telemedicine has accumulated experience, particularly in diabetic retinopathy screening. The guidelines by Horton et al. (2020) define implementation standards and quality assurance frameworks for teleophthalmology 10), and future application to the field of eye exams is anticipated.

Biomarker Research for AMD Risk Assessment

Section titled “Biomarker Research for AMD Risk Assessment”

Research by the EYE-RISK and European Eye Epidemiology Consortium has shown that high levels of high-density lipoprotein (HDL) cholesterol are associated with an increased risk of developing AMD 11). If AMD risk stratification using blood and tear biomarkers becomes feasible, it could be incorporated into eye exams to efficiently identify high-risk individuals 11).

  1. Iwase A, Suzuki Y, Araie M, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology. 2004;111(9):1641-1648.

  2. 日本緑内障学会. 緑内障診療ガイドライン(第5版). 日眼会誌. 2022;126(2):85-177.

  3. 日本糖尿病眼学会. 糖尿病網膜症診療ガイドライン(第1版). 日眼会誌. 2020;124(12):955-981.

  4. Ohno-Matsui K, Lai TY, Lai CC, et al. Updates of pathologic myopia. Prog Retin Eye Res. 2016;52:156-187.

  5. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254(5035):1178-1181.

  6. Nagiel A, Lalane RA, Sadda SR, et al. Ultra-widefield fundus imaging: a review of clinical applications and future trends. Retina. 2016;36(4):660-678.

  7. Ting DSW, Cheung CY, Lim G, et al. Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes. JAMA. 2017;318(22):2211-2223.

  8. Yasuda M, Kiyohara Y, Hata Y, et al. Nine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population: the Hisayama Study. Ophthalmology. 2009;116(11):2135-2140.

  9. Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 2006;124(12):1754-1760.

  10. Horton MB, Brady CJ, Cavallerano J, et al. Practice guidelines for ocular telehealth-diabetic retinopathy, third edition. Telemed J E Health. 2020;26(4):495-543.

  11. Colijn JM, den Hollander AI, Demirkan A, et al. Increased high-density lipoprotein levels associated with age-related macular degeneration: evidence from the EYE-RISK and European Eye Epidemiology Consortia. Ophthalmology. 2019;126(3):393-406.

Copy the article text and paste it into your preferred AI assistant.